已收盘 12-19 16:00:00 美东时间
-0.036
-10.74%
IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company leveraging Artificial Intelligence (AI) to develop innovative treatments for Alzheimer's disease, today announced that
12-19 22:02
Effective December 12, 2025, IGC Pharma, Inc. (the "Company") amended its Amended and Restated Articles of Incorporation in order to give effect to a previously announced increase of its authorized common stock from
12-16 05:22
Shares of cannabis-linked stocks are trading higher following a report suggesti...
12-12 21:23
https://www.marijuanamoment.net/nebraska-supreme-court-hears-case-seeking-to-overturn-medical-marijuana-law-approved-by-voters/
12-04 21:59
https://www.marijuanamoment.net/marijuana-banking-bill-is-on-the-back-burner-as-congressional-lawmakers-see-no-indication-itll-advance-soon/
11-25 23:27
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $191.000 thousand
11-17 21:38
https://patentcenter.uspto.gov/applications/18301099/ifw/docs
11-11 05:50
IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced an expansion of its
11-03 21:54
(来源:商图药讯) IGC参会指南 大会时间 2025年10月30日 星期四(Thursday 30 October, 2025) 签到时间 (R...
10-23 19:30
登录新浪财经APP 搜索【信披】查看更多考评等级 10月21日,宁波健信超导科技股份有限公司(简称健信超导)在科创板上会审...
10-22 12:46